Interim Operational Guidelines on the COVID-19 Vaccination of the Pediatric Population Ages 12-17 Years Old with Comorbidities

The guidelines shall cover the vaccination of the pediatric population aged 12-17 years old with comorbidities only. Only vaccines with Emergency Use Authorization (EUA) approval from the Food and Drug Administration (FDA) for 12 years and above shall be allocated to identified implementing units and vaccination sites (English).